Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of epoetin beta to maintain hemoglobin levels in hemodialysis patients
jRCT2080220011Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of epoetin beta in anemia of renal disease, sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
epoetin beta
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT2080220011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220011.